Viranuj Sueblinvong1, Daniel W Johnson, Gary L Weinstein, Michael J Connor, Ian Crozier, Allison M Liddell, Harold A Franch, Bruce R Wall, Andre C Kalil, Mark Feldman, Steven J Lisco, Jonathan E Sevransky. 1. 1Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Medicine, Emory University School of Medicine, Atlanta, GA. 2Division of Critical Care, Department of Anesthesiology, University of Nebraska Medical Center, Omaha, NE. 3Department of Internal Medicine, Division of Pulmonary and Critical Care Medicine, Texas Health Presbyterian Hospital, Dallas, TX. 4Division of Renal Medicine, Department of Medicine, Emory University School of Medicine, Atlanta, GA. 5Infectious Diseases Institute, Mulago Hospital Complex, Kampala, Uganda. 6Department of Internal Medicine, Division of Infectious Diseases, Texas Health Presbyterian Hospital, Dallas, TX. 7Department of Internal Medicine, Renal Section, Texas Health Presbyterian Hospital, Dallas, TX. 8Division of Infectious Diseases, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE. 9Department of Internal Medicine, Texas Health Presbyterian Hospital, Dallas, TX.
Abstract
OBJECTIVE: This report describes three patients with Ebola virus disease who were treated in the United States and developed for severe critical illness and multiple organ failure secondary to Ebola virus infection. The patients received mechanical ventilation, renal replacement therapy, invasive monitoring, vasopressor support, and investigational therapies for Ebola virus disease. DATA SOURCES: Patient medical records from three tertiary care centers (Emory University Hospital, University of Nebraska Medical Center, and Texas Health Presbyterian Dallas Hospital). STUDY SELECTION: Not applicable. DATA EXTRACTION: Not applicable. DATA SYNTHESIS: Not applicable. CONCLUSION: In the severe form, patients with Ebola virus disease may require life-sustaining therapy, including mechanical ventilation and renal replacement therapy. In conjunction with other reported cases, this series suggests that respiratory and renal failure may occur in severe Ebola virus disease, especially in patients burdened with high viral loads. Ebola virus disease complicated by multiple organ failure can be survivable with the application of advanced life support measures. This collective, multicenter experience is presented with the hope that it may inform future treatment of patients with Ebola virus disease requiring critical care treatment.
OBJECTIVE: This report describes three patients with Ebola virus disease who were treated in the United States and developed for severe critical illness and multiple organ failure secondary to Ebola virus infection. The patients received mechanical ventilation, renal replacement therapy, invasive monitoring, vasopressor support, and investigational therapies for Ebola virus disease. DATA SOURCES: Patient medical records from three tertiary care centers (Emory University Hospital, University of Nebraska Medical Center, and Texas Health Presbyterian Dallas Hospital). STUDY SELECTION: Not applicable. DATA EXTRACTION: Not applicable. DATA SYNTHESIS: Not applicable. CONCLUSION: In the severe form, patients with Ebola virus disease may require life-sustaining therapy, including mechanical ventilation and renal replacement therapy. In conjunction with other reported cases, this series suggests that respiratory and renal failure may occur in severe Ebola virus disease, especially in patients burdened with high viral loads. Ebola virus disease complicated by multiple organ failure can be survivable with the application of advanced life support measures. This collective, multicenter experience is presented with the hope that it may inform future treatment of patients with Ebola virus disease requiring critical care treatment.
Authors: Rashid Ansumana; Kathryn H Jacobsen; Foday Sahr; M'baimba Idris; Henry Bangura; Mohamed Boie-Jalloh; Joseph M Lamin; Santigie Sesay Journal: N Engl J Med Date: 2014-12-24 Impact factor: 91.245
Authors: Daniel W Johnson; James N Sullivan; Craig A Piquette; Angela L Hewlett; Kristina L Bailey; Philip W Smith; Andre C Kalil; Steven J Lisco Journal: Crit Care Med Date: 2015-06 Impact factor: 7.598
Authors: Tetsuro Ikegami; Mary Elizabeth G Miranda; Alan B Calaor; Daria L Manalo; Noel J Miranda; Masahiro Niikura; Masayuki Saijo; Yumi Une; Yasuo Nomura; Ichiro Kurane; Thomas G Ksiazek; Yasuhiro Yoshikawa; Shigeru Morikawa Journal: Exp Anim Date: 2002-10
Authors: Laurent Papazian; Jean-Marie Forel; Arnaud Gacouin; Christine Penot-Ragon; Gilles Perrin; Anderson Loundou; Samir Jaber; Jean-Michel Arnal; Didier Perez; Jean-Marie Seghboyan; Jean-Michel Constantin; Pierre Courant; Jean-Yves Lefrant; Claude Guérin; Gwenaël Prat; Sophie Morange; Antoine Roch Journal: N Engl J Med Date: 2010-09-16 Impact factor: 91.245
Authors: John S Schieffelin; Jeffrey G Shaffer; Augustine Goba; Michael Gbakie; Stephen K Gire; Andres Colubri; Rachel S G Sealfon; Lansana Kanneh; Alex Moigboi; Mambu Momoh; Mohammed Fullah; Lina M Moses; Bethany L Brown; Kristian G Andersen; Sarah Winnicki; Stephen F Schaffner; Daniel J Park; Nathan L Yozwiak; Pan-Pan Jiang; David Kargbo; Simbirie Jalloh; Mbalu Fonnie; Vandi Sinnah; Issa French; Alice Kovoma; Fatima K Kamara; Veronica Tucker; Edwin Konuwa; Josephine Sellu; Ibrahim Mustapha; Momoh Foday; Mohamed Yillah; Franklyn Kanneh; Sidiki Saffa; James L B Massally; Matt L Boisen; Luis M Branco; Mohamed A Vandi; Donald S Grant; Christian Happi; Sahr M Gevao; Thomas E Fletcher; Robert A Fowler; Daniel G Bausch; Pardis C Sabeti; S Humarr Khan; Robert F Garry Journal: N Engl J Med Date: 2014-10-29 Impact factor: 91.245
Authors: Jonathan S Towner; Pierre E Rollin; Daniel G Bausch; Anthony Sanchez; Sharon M Crary; Martin Vincent; William F Lee; Christina F Spiropoulou; Thomas G Ksiazek; Mathew Lukwiya; Felix Kaducu; Robert Downing; Stuart T Nichol Journal: J Virol Date: 2004-04 Impact factor: 5.103
Authors: Xiangguo Qiu; Gary Wong; Jonathan Audet; Alexander Bello; Lisa Fernando; Judie B Alimonti; Hugues Fausther-Bovendo; Haiyan Wei; Jenna Aviles; Ernie Hiatt; Ashley Johnson; Josh Morton; Kelsi Swope; Ognian Bohorov; Natasha Bohorova; Charles Goodman; Do Kim; Michael H Pauly; Jesus Velasco; James Pettitt; Gene G Olinger; Kevin Whaley; Bianli Xu; James E Strong; Larry Zeitlin; Gary P Kobinger Journal: Nature Date: 2014-08-29 Impact factor: 49.962
Authors: Anita K McElroy; Jessica R Harmon; Timothy D Flietstra; Shelley Campbell; Aneesh K Mehta; Colleen S Kraft; Marshall G Lyon; Jay B Varkey; Bruce S Ribner; Christopher J Kratochvil; Peter C Iwen; Philip W Smith; Rafi Ahmed; Stuart T Nichol; Christina F Spiropoulou Journal: Clin Infect Dis Date: 2016-06-27 Impact factor: 9.079
Authors: Russell Byrum; Lauren Keith; Christopher Bartos; Marisa St Claire; Matthew G Lackemeyer; Michael R Holbrook; Krisztina Janosko; Jason Barr; Daniela Pusl; Laura Bollinger; Jiro Wada; Linda Coe; Lisa E Hensley; Peter B Jahrling; Jens H Kuhn; Margaret R Lentz Journal: J Vis Exp Date: 2016-10-03 Impact factor: 1.355
Authors: Timothy M Uyeki; Aneesh K Mehta; Richard T Davey; Allison M Liddell; Timo Wolf; Pauline Vetter; Stefan Schmiedel; Thomas Grünewald; Michael Jacobs; Jose R Arribas; Laura Evans; Angela L Hewlett; Arne B Brantsaeter; Giuseppe Ippolito; Christophe Rapp; Andy I M Hoepelman; Julie Gutman Journal: N Engl J Med Date: 2016-02-18 Impact factor: 91.245
Authors: Shevin T Jacob; Ian Crozier; William A Fischer; Angela Hewlett; Colleen S Kraft; Marc-Antoine de La Vega; Moses J Soka; Victoria Wahl; Anthony Griffiths; Laura Bollinger; Jens H Kuhn Journal: Nat Rev Dis Primers Date: 2020-02-20 Impact factor: 52.329
Authors: William A Fischer; Pauline Vetter; Daniel G Bausch; Timothy Burgess; Richard T Davey; Robert Fowler; Frederick G Hayden; Peter B Jahrling; Andre C Kalil; Douglas L Mayers; Aneesh K Mehta; Timothy M Uyeki; Michael Jacobs Journal: Lancet Infect Dis Date: 2017-11-15 Impact factor: 25.071